File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)

TitleTuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
Authors
Li, XPeng, KCheng, FWTLam, DCLCheung, CLChui, CSLLai, FTTWan, EYFWong, CKHMa, TTYum, SHHChan, EWYHuang, JDLau, CSIp, MSMWong, ICK
KeywordsCOVID-19 vaccines
Innate immunity
Tuberculosis
Issue Date16-Dec-2022
PublisherBritish Infection Association
Citation
Journal of Infection, 2023, v. 86, n. 3, p. 256-308 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jinf.2022.12.016
Persistent Identifierhttp://hdl.handle.net/10722/329034
ISSN
0163-4453
2021 Impact Factor: 38.637
2020 SCImago Journal Rankings: 1.946

 

DC FieldValueLanguage
dc.contributor.authorLi, X-
dc.contributor.authorPeng, K-
dc.contributor.authorCheng, FWT-
dc.contributor.authorLam, DCL-
dc.contributor.authorCheung, CL-
dc.contributor.authorChui, CSL-
dc.contributor.authorLai, FTT-
dc.contributor.authorWan, EYF-
dc.contributor.authorWong, CKH-
dc.contributor.authorMa, TT-
dc.contributor.authorYum, SHH-
dc.contributor.authorChan, EWY-
dc.contributor.authorHuang, JD-
dc.contributor.authorLau, CS-
dc.contributor.authorIp, MSM-
dc.contributor.authorWong, ICK-
dc.date.accessioned2023-08-05T07:54:46Z-
dc.date.available2023-08-05T07:54:46Z-
dc.date.issued2022-12-16-
dc.identifier.citationJournal of Infection, 2023, v. 86, n. 3, p. 256-308-
dc.identifier.issn0163-4453-
dc.identifier.urihttp://hdl.handle.net/10722/329034-
dc.languageeng-
dc.publisherBritish Infection Association-
dc.relation.ispartofJournal of Infection-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCOVID-19 vaccines-
dc.subjectInnate immunity-
dc.subjectTuberculosis-
dc.titleTuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)-
dc.typeArticle-
dc.identifier.doi10.1016/j.jinf.2022.12.016-
dc.identifier.scopuseid_2-s2.0-85149415600-
dc.identifier.volume86-
dc.identifier.issue3-
dc.identifier.spage256-
dc.identifier.epage308-
dc.identifier.eissn1532-2742-
dc.identifier.issnl0163-4453-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats